About this trial
This prospective randomized controlled study aims to compare the effects of ultrasound-guided thoracolumbar interfascial plane (TLIP) block versus retrolaminar block on postoperative quality of recovery in patients undergoing posterior lumbar spine fusion surgery. Despite advances in surgical techniques, lumbar spine fusion is associated with significant postoperative pain, which may delay recovery and increase opioid consumption.
Recent approaches emphasize multimodal analgesia and opioid-sparing strategies, including regional anesthesia techniques. Interfascial plane blocks, such as TLIP and retrolaminar block, have gained attention due to their safety and effectiveness in targeting the dorsal rami of spinal nerves supplying the posterior spinal structures.
The primary outcome of this study is postoperative quality of recovery assessed using the Quality of Recovery-15 (QoR-15) questionnaire at 24 hours. Secondary outcomes include pain scores, opioid consumption, time to ambulation, time to oral intake, and postoperative complications.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients aged 18-65 years
Male and female patients
Scheduled for elective one- or two-level posterior lumbar instrumented fusion surgery under general anesthesia
ASA physical status I-III
Disqualifiers
Patient refusal to participate
Coagulopathy or anticoagulant therapy
Infection at the site of block injection
Known allergy to local anesthetics
Trial design
Parallel
Treatments tested in this trial
Thoracolumbar interfascial plane block
Procedure/SurgeryUltrasound-guided injection of local anesthetic into the fascial plane between the multifidus and longissimus muscles at the L3 level
Retrolaminar block
Procedure/SurgeryUltrasound-guided injection of local anesthetic posterior to the vertebral lamina at the L3 level.
Treatment groups
Trial outcomes
Primary outcomes
Quality of Recovery-15 (QoR-15) score at 24 hours postoperatively
Quality of recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire, a validated 15-item patient-reported outcome measure. Scores range from 0 to 150, with higher scores indicating better postoperative recovery. The primary endpoint is the QoR-15 score at 24 hours after surgery.
Secondary outcomes
Pain intensity using Visual Analog Scale (VAS)
Pain will be assessed using a 0-10 Visual Analog Scale, where 0 indicates no pain and 10 indicates worst imaginable pain.
Time to first rescue analgesia
Time from the end of surgery to the first request for rescue analgesia (VAS ≥ 4).
Total nalbuphine consumption
Total amount of nalbuphine administered within the first 24 hours after surgery (mg).
Time to first ambulation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: